Beijing Kawin Technology Share-holding Co Ltd (688687) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Beijing Kawin Technology Share-holding Co Ltd (688687) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.41 Million ≈ $3.86 Million USD) by net assets (CN¥1.83 Billion ≈ $267.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Beijing Kawin Technology Share-holding C worth for the company's overall valuation and market capitalisation.

Beijing Kawin Technology Share-holding Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Beijing Kawin Technology Share-holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Kawin Technology Share-holding Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Kawin Technology Share-holding Co Ltd ranked by their cash flow conversion efficiency. Explore Beijing Kawin Technology Share-holding C cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Elite Color Environmental Resources 
SHE:002998
0.002x
Guizhou Transp Planning
SHG:603458
0.028x
Yuancheng Cable Co Ltd
SHE:002692
0.145x
Hangzhou Wensli Silk Culture Co. Ltd.
SHE:301066
N/A
Strata Critical Medical, Inc.
NASDAQ:SRTA
0.012x
Regal Partners Global Investments Limited
AU:RG1
0.038x
Magnera Corp placeholder
NYSE:MAGN
-0.013x
Shenzhen Zqgame
SHE:300052
0.010x

Annual Cash Flow Conversion Efficiency for Beijing Kawin Technology Share-holding Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Kawin Technology Share-holding Co Ltd from 2009 to 2025. View current stock price of Beijing Kawin Technology Share-holding C for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.74 Billion
≈ $254.60 Million
CN¥110.29 Million
≈ $16.14 Million
0.063x +14.30%
2024-12-31 CN¥1.88 Billion
≈ $275.15 Million
CN¥104.29 Million
≈ $15.26 Million
0.055x -21.79%
2023-12-31 CN¥1.79 Billion
≈ $261.23 Million
CN¥126.60 Million
≈ $18.53 Million
0.071x -11.02%
2022-12-31 CN¥1.68 Billion
≈ $246.10 Million
CN¥134.05 Million
≈ $19.62 Million
0.080x +14.04%
2021-12-31 CN¥1.69 Billion
≈ $246.93 Million
CN¥117.94 Million
≈ $17.26 Million
0.070x -54.60%
2020-12-31 CN¥853.63 Million
≈ $124.91 Million
CN¥131.42 Million
≈ $19.23 Million
0.154x +15.43%
2019-12-31 CN¥771.85 Million
≈ $112.95 Million
CN¥102.94 Million
≈ $15.06 Million
0.133x +44.82%
2018-12-31 CN¥654.87 Million
≈ $95.83 Million
CN¥60.31 Million
≈ $8.83 Million
0.092x +297.24%
2017-12-31 CN¥612.36 Million
≈ $89.61 Million
CN¥14.20 Million
≈ $2.08 Million
0.023x +55.63%
2015-12-31 CN¥545.83 Million
≈ $79.87 Million
CN¥8.13 Million
≈ $1.19 Million
0.015x -92.81%
2014-12-31 CN¥239.73 Million
≈ $35.08 Million
CN¥49.67 Million
≈ $7.27 Million
0.207x +172.70%
2013-12-31 CN¥220.74 Million
≈ $32.30 Million
CN¥16.77 Million
≈ $2.45 Million
0.076x -56.11%
2012-12-31 CN¥163.93 Million
≈ $23.99 Million
CN¥28.38 Million
≈ $4.15 Million
0.173x -34.24%
2011-12-31 CN¥122.53 Million
≈ $17.93 Million
CN¥32.26 Million
≈ $4.72 Million
0.263x -2.90%
2010-12-31 CN¥92.84 Million
≈ $13.59 Million
CN¥25.17 Million
≈ $3.68 Million
0.271x -39.47%
2009-12-31 CN¥38.91 Million
≈ $5.69 Million
CN¥17.43 Million
≈ $2.55 Million
0.448x --

About Beijing Kawin Technology Share-holding Co Ltd

SHG:688687 China Biotechnology
Market Cap
$446.51 Million
CN¥3.05 Billion CNY
Market Cap Rank
#13003 Global
#3870 in China
Share Price
CN¥17.85
Change (1 day)
+0.79%
52-Week Range
CN¥15.01 - CN¥31.70
All Time High
CN¥40.56
About

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more